Media coverage about Henry Schein (NASDAQ:HSIC) has been trending somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Henry Schein earned a daily sentiment score of 0.20 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.9388839627439 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

A number of brokerages have commented on HSIC. Zacks Investment Research upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, January 4th. Royal Bank of Canada dropped their target price on shares of Henry Schein from $91.00 to $82.00 and set a “sector perform” rating on the stock in a research note on Tuesday, November 7th. Jefferies Group restated a “hold” rating and issued a $89.00 target price on shares of Henry Schein in a research note on Friday, October 20th. Stephens began coverage on shares of Henry Schein in a research note on Tuesday, November 28th. They issued an “equal weight” rating and a $76.00 target price on the stock. Finally, Morgan Stanley downgraded shares of Henry Schein from an “equal weight” rating to an “underweight” rating and set a $88.00 target price on the stock. in a research note on Wednesday, December 6th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $84.23.

Shares of Henry Schein (HSIC) traded down $2.55 on Monday, hitting $71.80. 1,900,774 shares of the stock traded hands, compared to its average volume of 1,560,761. Henry Schein has a 52-week low of $65.28 and a 52-week high of $93.50. The stock has a market cap of $11,669.56, a PE ratio of 20.69, a PEG ratio of 1.91 and a beta of 1.00. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.55 and a quick ratio of 0.86.

In other news, Director Barry J. Alperin sold 5,796 shares of the company’s stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $70.76, for a total value of $410,124.96. Following the completion of the sale, the director now owns 48,172 shares of the company’s stock, valued at approximately $3,408,650.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.19% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: This piece of content was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another publication, it was stolen and reposted in violation of United States & international copyright and trademark laws. The correct version of this piece of content can be read at https://www.watchlistnews.com/henry-schein-hsic-earning-somewhat-favorable-news-coverage-analysis-finds/1846730.html.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Insider Buying and Selling by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.